Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini(Istituto di Ematologia di Bologna), Mohamad Mohty(Sorbonne Université), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(Vita-Salute San Raffaele University), Patrice Chevallier(Hotel Dieu Hospital), Myriam Labopin(Sorbonne Université), Francesco Lanza(Istituti Ospitalieri di Cremona), Zafer Gülbaş, Arnon Nagler(Sheba Medical Center), Mercedes Colorado Araujo(Marqués de Valdecilla University Hospital), Yener Koç(Antalya IVF), Gèrard Socié(Hôpital Saint-Louis), Véronique Leblond(Sorbonne Université), Éric Deconinck(European Union)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k